COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents

Coronavirus Clinical Trial

Official title:

Multilevel Participatory Intervention to Reduce Barriers and Promote Social and Behavioral Facilitators of COVID-19 Testing Among African Americans and Latinx Public Housing Residents

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04542395
• Other study ID #: COVID19testingvacc
• Status: Withdrawn
• Phase: N/A
• Start date: June 1, 2023
• Est. completion date: November 30, 2025

Study information

• Verified date: August 2022
• Source: Charles Drew University of Medicine and Science
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This proposal seeks to enhance acceptability and uptake of COVID-19 testing and vaccination to engage African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to reduce barriers and implement innovate strategies to engage this population in the uptake of COVID-19 testing and vaccination.

Description:

Through the engagement and empowerment of 15 trained COVID-19 health ambassadors, the investigators will jointly implement and evaluate a theoretically based and culturally-sensitive socio-behavioral intervention that will: a) reduce mistrust, fatalistic beliefs, and related psychosocial barriers that hinder COVID-19 testing and vaccination; b) increase receptivity and willingness for uptake of COVID-19 testing and vaccination; and c) assess perceived impact of psychosocial and health outcomes related to COVID-19 testing and vaccination for 310 African American and Latinx public housing residents.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: November 30, 2025
• Est. primary completion date: November 30, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Identify as Latino/Hispanic or African American/Black

• Reside in one of the six collaborating public housing

• 18 years old and older

• Speak either English or Spanish

Exclusion Criteria:

• Does not self-identify as African American and/or Black

• Under the age of 18

• Unable to speak English or Spanish

• Does not Reside in one of the six collaborating public housing

Related Conditions & MeSH terms

• Coronavirus
• Coronavirus Infections

Intervention

Behavioral:
• Increasing Willingness and Uptake of COVID-19 Testing and Vaccination
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges and increase willingness and uptake in COVID-19 testing and vaccination.

Locations

Country	Name	City	State
United States	Housing Authority of Clty of Los Angeles	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
Charles Drew University of Medicine and Science

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of COVID-19 testing, pneumococcal and influenza vaccinations Using Test History Self-Report	By comparison of pre-, post- intervention, and six-months follow-up data, we anticipate the following compared to baseline: a 30% change in willingness and uptake for testing and vaccination.	Intervention: 3 months; Follow-up Point: 6 months post-intervention
Primary	Percentage of Participants Achieving Decreased Levels of COVID-19 Risk Using the NIH Toolbox Surveys on COVID-19	By comparison of pre-, post- intervention, and six-months follow-up data, we anticipate the following compared to baseline: a 30% change in perceived COVID-19 risk.	Intervention: 3 months; Follow-up Point: 6 months post-intervention
Primary	Percentage of Participants Achieving Decreased Levels of COVID-19 Mistrust and Barriers Using the NIH Toolbox Surveys on COVID-19	By comparison of pre-, post- intervention, and six-months follow-up data, we anticipate the following compared to baseline: a 40% change in mistrust and perceived barriers toward COVID-19 testing and vaccination,	Intervention: 3 months; Follow-up Point: 6 months post-intervention